The researchers said that better diagnostics are needed to distinguish between false preterm labor and true preterm labor to prevent unnecessary treatment.
In a wide-ranging discussion, the two leaders touched upon vaccine development, infant mortality, US education, research funding, machine learning, and precision medicine.
A new genome-wide association study involving data from thousands of 23andMe customers implicated six loci in gestational duration or preterm birth risk.
The study details the validation of the mass spec-based preterm birth test, which the company launched nationwide last month through its agreement with LabCorp.
In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.
